|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash interest income (expense), net | |||||
| Non-cash change in investments | |||||
| Change in deferred revenue | |||||
| Deferred income taxes | |||||
| Share-based compensation | |||||
| Loss on extinguishment of debt | |||||
| Impairment of assets | |||||
| Other | |||||
| Decrease (Increase) in assets: | |||||
| Receivables | |||||
| Deferred charges and other assets | |||||
| Increase (Decrease) in liabilities: | |||||
| Accounts payable | |||||
| Customer deposit | |||||
| Accrued compensation and other expenses | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of short-term investments | |||||
| Proceeds from maturities and sales of short-term investments | |||||
| Purchases of property and equipment | |||||
| Capitalized patent costs | |||||
| Acquisitions | |||||
| Long-term investments | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of convertible senior notes | |||||
| Purchase of convertible bond hedge | |||||
| Proceeds from issuance of warrants | |||||
| Proceeds from bond hedge unwind | |||||
| Payment for warrant unwind and settlement | |||||
| Payments of debt issuance costs | |||||
| Repurchase of common stock | |||||
| Taxes paid on the repurchase of common stock | |||||
| Net proceeds from exercise of stock options | |||||
| Non-controlling interest contribution | |||||
| Non-controlling interest distribution | |||||
| Taxes withheld upon restricted stock unit vestings | |||||
| Dividends paid | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
Loading...